17 October 2021
11 Rabee' Al-Awwal 1443
عربي
Article 10 - (Amended By Law 4 /2011) Starting Date : 31/03/2011 The licence application for establishing a pharmaceutical Establishment shall be submitted to the competent authority and shall include the following information: First: For individual property: The applicant's full name. Date of birth. Profession. Nationality. Address. Second: for the company: The company's name and its commercial character and address. The company's type and its capital. The partners' names; their age, nationalities and their respective share in the company's capital; The names of people authorized to manage or sign. The duration of the company. The application shall be accompanied by the following documents: A birth certificate, true copy or an equivalent official document. A nationality certificate, true copy or an equivalent official document. Proof that the applicant does not have any criminal record for transgressions involving moral dishonesty. An architectural plan of the Establishment, in triplicate, showing its location and its interior layout. A receipt confirming payment of the licence fee, amounting to five hundred (500) Qatari Riyals payable to the Council treasury. Where the licensee is a company, the application shall be accompanied by a copy of the company's Memorandum of Association and the documents set forth in clauses 1-3 of this Article to each partner responsible for the management. Where the submitted application fulfills these requirements, it shall be listed in the corresponding record in the competent authority. The applicant shall also be given a receipt confirming the entry of his application into the record, and the date of this entry. The rejection decisions should be justified, and the applicant shall be notified of this decision within two weeks of the date of its issuance by registered letter. The applicant may appeal against this rejection to the Minister within a period of two months from the date of his notification. The appeal must be evidence based, and must include supporting documentation. The Minister may issue a decision either rejecting the complaint or else the Minister may request a review by the Committee. The Committee's decision in this regard shall not be final unless approved by the Minister.
Article 10 - (Amended By Law 4 /2011) Starting Date : 31/03/2011
Last Article Text (Amended By Law 4 / 2001) Starting Date : 22/04/2001 Expiry Date: 31/03/2011
The licence application for establishing a pharmaceutical Establishment shall be submitted to the competent authority and shall include the following information: First: For individual property: The applicant's full name. Date of birth. Profession. Nationality. Address. Second: for the company: The company's name and its commercial character and address. The company's type and its capital. The partners' names; their age, nationalities and their respective share in the company's capital; The names of people authorized to manage or sign. The duration of the company. The application shall be accompanied by the following documents: A birth certificate, true copy or an equivalent official document. A nationality certificate, true copy or an equivalent official document. Proof that the applicant does not have any criminal record for transgressions involving moral dishonesty. An architectural plan of the Establishment, in triplicate, showing its location and its interior layout. A receipt confirming payment of the licence fee, amounting to five hundred (500) Qatari Riyals payable to the Council treasury. Where the licensee is a company, the application shall be accompanied by a copy of the company's Memorandum of Association and the documents set forth in the clauses from 1-3 of this Article to each partner responsible for the management. Where the submitted application fulfills these requirements, it shall be listed in the corresponding record in the competent authority. The applicant shall also be given a receipt confirming the entry of his application into the record, and the date of this entry. The rejection decisions should be justified, and the applicant shall be notified of this decision within two weeks of the date of its issuance by registered letter. The applicant may appeal against this rejection to the Minister within a period of two months from the date of his notification. The appeal must be evidence based, and must include supporting documentation. The Minister may issue a decision either rejecting the complaint or else the Minister may request a review by the Committee. The Committee's decision in this regard shall not be final unless approved by the Minister.
Last Article Text Starting Date : 01/01/1983 Expiry Date: 22/04/2001
The licence application for establishing a pharmaceutical Establishment shall be submitted to the competent authority and shall include the following information: First: For individual property: The applicant's full name. Date of birth. Profession. Nationality. Address. Second: for the company: The company's name and its commercial character and address. The company's type and its capital. The partners' names; their age, nationalities and their respective share in the company's capital; The names of people authorized to manage or sign. The duration of the company. The application shall be accompanied by the following documents: A birth certificate, true copy or an equivalent official document. A nationality certificate, true copy or an equivalent official document. Proof that the applicant does not have any criminal record for transgressions involving moral dishonesty. An architectural plan of the Establishment, in triplicate, showing its location and its interior layout. A receipt confirming payment of the licence fee, amounting to five hundred (500) Qatari Riyals payable to the Ministry treasury. Where the licensee is a company, the application shall be accompanied by a copy of the company's Memorandum of Association and the documents set forth in clauses 1-3 of this Article to each partner responsible for the management. Where the submitted application fulfills these requirements, it shall be listed in the corresponding record in the competent authority. The applicant shall also be given a receipt confirming the entry of his application into the record, and the date of this entry. The rejection decisions should be justified, and the applicant shall be notified of this decision within two weeks of the date of its issuance by registered letter. The applicant may appeal against this rejection to the Minister within a period of two months from the date of his notification. The appeal must be evidence based, and must include supporting documentation. The Minister may issue a decision either rejecting the complaint or else he may request a review by the Committee. The Committee's decision in this concern is not final unless approved by the Minister.